Show simple item record

dc.contributor.authorIrish Medicines Board (IMB)
dc.date.accessioned2012-09-19T22:42:15Z
dc.date.available2012-09-19T22:42:15Z
dc.date.issued2002-05-02
dc.identifier.urihttp://hdl.handle.net/10147/245111
dc.descriptionThe Irish Medicines Board [IMB] hosted a seminar on the implications of the proposed interim national licensing scheme for traditional medicinal products at the Hilton Dublin Hotel on 2nd May 2002. A total of 111 attendees were present at the seminar including 10 IMB staff, 2 representatives from the Food Safety Authority of lreland and 5 representatives from the Medicines Unit of the Department of Health and Children. Attendees included representatives from the health trade industry and representatives from all interested organisations including two consumer organisations. Consumers for Health Choice (CHC) and Consumers' Association of Ireland (CAI)en_GB
dc.language.isoenen
dc.publisherIrish Medicines Board (IMB)en_GB
dc.subjectMEDICINESen_GB
dc.subjectCONSUMERen_GB
dc.titleIrish Medicines Board seminar report: implications of the proposed interim national licencing scheme for traditional medicinal productsen_GB
dc.typeReporten
refterms.dateFOA2018-08-22T22:31:40Z


Files in this item

Thumbnail
Name:
IrishMedicinesBoardSeminarRepo ...
Size:
3.159Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record